Rare diseases
Investigational molecules
Locations
Gentzgasse 60/21, Waehring, 1180 Vienna, Austria
Research activity is centered on newly diagnosed multiple myeloma in older adults, with particular attention to treatment strategies for patients aged 70 years and above. The clinical focus includes disease control in a population with age-related treatment considerations and the use of monoclonal antibody-based regimens in haematologic malignancy.
The sponsor’s trial portfolio reflects interest in improving outcomes for older patients with plasma cell disorders, including disease response assessment and deeper remission endpoints such as minimal residual disease negativity.
Arbeitsgemeinschaft Medikamentoese Tumortherapie gGmbH runs clinical trials in conditions such as Plasma cell myeloma, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
